MedSci Healthcare Holdings Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. The Group is expected to record a profit attributable to the Shareholders of approximately around RMB 10 million for the six months ended 30 June 2023 as compared to a net loss attributable to the Shareholders recorded for the six months ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 HKD | 0.00% | -4.36% | -44.86% |
04-26 | Certain Shares of MedSci Healthcare Holdings Limited are subject to a Lock-Up Agreement Ending on 26-APR-2024. | CI |
04-01 | Medsci Healthcare Rebounds to 2023 Profit | MT |
1st Jan change | Capi. | |
---|---|---|
-44.86% | 180M | |
-26.05% | 2.73B | |
-21.73% | 2.64B | |
-49.92% | 2.37B | |
-43.39% | 261M | |
-2.11% | 217M | |
-32.96% | 114M |
- Stock Market
- Equities
- 2415 Stock
- News MedSci Healthcare Holdings Limited
- MedSci Healthcare Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023